Axa S.A. Acadia Pharmaceuticals Inc Transaction History

Axa S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $261,120 - $334,720	16,000 New	16,000 $301,000
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $490,291 - $1.08 Million	-19,596 Reduced 20.71%	75,017 $1.94 Million
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $2.53 Million - $3.5 Million	-61,612 Reduced 39.44%	94,613 $5.06 Million
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $1.42 Million - $2.22 Million	38,904 Added 33.16%	156,225 $6.45 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $1.39 Million - $1.87 Million	35,400 Added 43.21%	117,321 $5.69 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $2.16 Million - $3.21 Million	-68,383 Reduced 45.5%	81,921 $3.46 Million
Q4 2019 Feb 18, 2020	BUY	$36.21 - $51.4 $2.54 Million - $3.6 Million	70,104 Added 87.41%	150,304 $6.43 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $1.78 Million - $3.53 Million	80,200 New	80,200 $2.89 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.